Drawing on its international network, Baker McKenzie Switzerland AG offers expertise across the full range of issues affecting healthcare and life sciences companies, from M&A, reorganisations and carve-outs to licencing, regulatory compliance and IP matters. Olha Demianiuk heads up team alongside Julia Schieber. Demianiuk’s expertise lies in M&A transactions, while Schieber oversees IP transactions within the healthcare industry.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Testimonials
Collated independently by Legal 500 research team.
- ‘The team is composed of highly skilled professionals with diverse backgrounds, bringing a wealth of experience across corporate, regulatory and employment-related matters.'
- 'The practice is particularly strong in cross-border matters, offering seamless coordination and insight across jurisdictions.'
- 'I had a fantastic experience working with Olha Demianiuk. She did an outstanding job, not only in handling the legal aspects but also, and most impressively, in managing the seller relationship, which proved to be both exciting and demanding.'
- 'Julia Schieber has excellent drafting skills and provides very hands on advice, offering alternatives based on her knowledge of multiple deals she's supported.'
Key clients
- Abbott
- AbbVie
- Actelion Pharmaceuticals AG
- Adagene AG
- Akroswiss AG
- Alexion
- Allecra Therapeutics AG
- Almirall S.L.
- Araris Biotech
- Argenx SE
- Aricium
- Baitella Holding AG
Work highlights
Advised Novonesis on its €1.5bn acquisition of dsm-firmenich’s share of the Feed Enzyme Alliance.
Advised Numab Therapeutics on its $1.25bn sale of its atopic dermatitis spin-off to Johnson & Johnson.
Advised Araris Biotech AG on its research collaboration and option to license agreement with Chugai Pharmaceutical Co., Ltd.
Lawyers
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Olha Demianiuk; Julia Schieber